StonvexLoading…
StonvexStonvexStonvexCore line items from TWST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $214.41M | $103.70M | $376.57M | $277.56M |
Operating Income | $-78.76M | $-32.90M | $-136.26M | $-106.33M |
Net Income | $-74.53M | $-30.51M | $-77.67M | $-50.53M |
EPS (Diluted) | $-1.21 | $-0.50 | $-1.30 | $-0.85 |
Total Assets | $676.21M | $638.09M | $641.86M | $643.61M |
Total Liabilities | $221.12M | $181.99M | $168.90M | $165.41M |
Cash & Equivalents | $122.67M | $148.59M | $183.05M | $201.37M |
Free Cash Flow OCF − CapEx | $-60.23M | $-34.79M | $-75.63M | $-51.39M |
Shares Outstanding | 62.15M | 61.27M | 60.63M | 60.17M |